Search

Hikma Pharmaceuticals PLC

Deschisă

SectorSănătate

1,898 -1.35

Rezumat

Modificarea prețului

24h

Curent

Minim

1877

Maxim

1928

Indicatori cheie

By Trading Economics

Venit

-93M

133M

Vânzări

-11M

1.6B

P/E

Medie Sector

15.451

57.333

EPS

1.27

Randament dividend

3.24

Marjă de profit

8.537

Angajați

9,500

EBITDA

-211M

288M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+27.23% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

3.24%

2.63%

Statistici piață

By TradingEconomics

Capitalizare de piață

-930M

4.2B

Deschiderea anterioară

1899.35

Închiderea anterioară

1898

Hikma Pharmaceuticals PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

8 apr. 2025, 08:20 UTC

Market Talk

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

Hikma Pharmaceuticals PLC Așteptări

Obiectiv de preț

By TipRanks

27.23% sus

Prognoză pe 12 luni

Medie 2,422.5 GBX  27.23%

Maxim 2,650 GBX

Minim 2,000 GBX

În baza a 7 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruHikma Pharmaceuticals PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

7 ratings

5

Cumpărare

2

Păstrare

0

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.